multiplex massarray systems agena bioscience tm (agena bioscience)
agena bioscience is a verified supplier 
agena bioscience manufactures this product 
90
Structured Review
agena bioscience
multiplex massarray systems agena bioscience tm
Multiplex Massarray Systems Agena Bioscience Tm, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/agena+bioscience+tm/agena+massarray+platform/pmc09407577-175-1-4
Average 90 stars, based on 1 article reviews
Multiplex Massarray Systems Agena Bioscience Tm, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/agena+bioscience+tm/agena+massarray+platform/pmc09407577-175-1-4
Average 90 stars, based on 1 article reviews
multiplex massarray systems agena bioscience tm - by Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "Single Nucleotide Polymorphisms in Amlodipine-Associated Genes and Their Correlation with Blood Pressure Control among South African Adults with Hypertension"
Article Title: Single Nucleotide Polymorphisms in Amlodipine-Associated Genes and Their Correlation with Blood Pressure Control among South African Adults with Hypertension
Journal: Genes
doi: 10.3390/genes13081394
Figure Legend Snippet: Selected amlodipine variants used in the design of multiplex MassARRAY panels ( n = 13).
Techniques Used: Multiplex Assay
Related Articles
other:Article Title: Autosomal sdY Pseudogenes Explain Discordances Between Phenotypic Sex and DNA Marker for Sex Identification in Atlantic Salmon Article Snippet: This analysis was performed on a MassARRAY Analyzer 4 from Article Title: P.084 Predictors of brexpiprazole discontinuation after initiating or switching to brexpiprazole in patients with schizophrenia spectrum disorders Article Snippet: s S77 During a follow-up period of 100 days, 24 (40.0%) patients discontinued the brexpiprazole treatment.. 22 (24.4%) subjects discontinued due to a lack of efficacy, 7 (7.8%: 6, extrapyramidal side effects; 1, weight gain) more due to intolerability and a further 7 (7.8%) for other reasons.. The Cox multivariate regression analysis showed that having been subject to a higher dose of previous antipsychotics (CPequivalent doses of more than 800 mg) was independently associated with an increased risk of brexpiprazole discontinuation (HR = 2.80, 95% confidence interval = 1.18-6.68, P = 0.020). |